Pleasant Hill, CA, United States of America

Paul Andrew Barsanti

This inventor holds 25 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Kinase Inhibitors. Top assignees: Novartis Ag, Novartis Vaccines & Diagnostics, Gmbh. Active years: 2008-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Andrew Barsanti. Retrieved from https://idiyas.com/inventor/paul-andrew-barsanti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 10)

% Patents Active = 32.0

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 10.0

ph-index = 5

Forward Citations = 184(Granted Patents)

Location History:

Moraga, CA (US) (2009)
Emeryville, CA (US) (2010 - 2012)
Pleasant Hill, CA (US) (2008 - 2020)

Company Filing History:

Novartis Vaccines & Diagnostics, Gmbh

patents

Years Active: 2008-2020

Loading Chart...

Areas of Expertise:

Biaryl Amide Compounds

Kinase Inhibitors

Cell Proliferation Inhibitors

Pyrimidine Derivatives

Kinesin Inhibitors

Oxazole Compounds

Thiazole Compounds

Substituted Imidazole

Triazole Compounds

Heteroaryl Compounds

Anti-Cancer Agents

Thiosemicarbazones

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10709712 - Biaryl amide compounds as kinase inhibitors (2020-07-14),

2. 10392404 - Compounds and compositions as kinase inhibitors (2019-08-27),

3. 10245267 - Biaryl amide compounds as kinase inhibitors (2019-04-02),

4. 9694016 - Biaryl amide compounds as kinase inhibitors (2017-07-04),

5. 9498540 - Cell proliferation inhibitors and conjugates thereof (2016-11-22),

6. 9242969 - Biaryl amide compounds as kinase inhibitors (2016-01-26),

7. 8778951 - Heteroaryl compounds and their uses (2014-07-15),

8. 8748626 - Oxazole and thiazole compounds as KSP inhibitors (2014-06-10),

9. 8735599 - Substituted imidazole derivates (2014-05-27),

10. 8664256 - Kinesin inhibitors as cancer therapeutics (2014-03-04),

11. 8563549 - Pyrimidine derivatives used as PI-3 kinase inhibitors (2013-10-22),

12. 8546434 - Triazole compounds as KSP inhibitors (2013-10-01),

13. 8415381 - Heteroaryl compounds and their uses (2013-04-09),

14. 8318791 - Substituted imidazole derivatives (2012-11-27),

15. 8252832 - Kinesin inhibitors as cancer therapeutics (2012-08-28),

Title: The Innovative Journey of Paul Andrew Barsanti

Introduction: Paul Andrew Barsanti, a talented inventor hailing from Pleasant Hill, CA (US), has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Paul Andrew Barsanti's latest patents showcase his commitment to pushing boundaries in various industries, including technology, healthcare, and sustainability. His recent inventions have been recognized for their ingenuity and practicality.

Career Highlights: Throughout his illustrious career, Paul Andrew Barsanti has demonstrated a remarkable ability to transform ideas into tangible inventions that have the potential to improve lives. His passion for innovation has led to the development of groundbreaking solutions that address complex challenges.

Collaborations: Paul Andrew Barsanti has collaborated with leading experts in the field to bring his inventions to life. His partnerships with top researchers, engineers, and designers have resulted in successful projects that have garnered attention on a global scale.

Conclusion: In conclusion, Paul Andrew Barsanti's innovative spirit and relentless pursuit of excellence have established him as a prominent figure in the world of inventions. His remarkable contributions continue to inspire future generations of inventors to think outside the box and create a better world through innovation.

Profile summary based on public USPTO records.